Matthias Bozza
Director, Research & Development Head of Strategy CPTx
Matthias Bozza is a company builder, drug developer, and life sciences innovator focused on gene and cell therapy and oncology. Recognized as one of the most talented Italian scientists under 35 in the healthcare sector and a recipient of the Waltraud-Lewenz Award for experimental medicine, Matthias works at the intersection of innovation and therapeutic development. At CPTx, Matthias contributes to advancing programmable DNA medicines and next-generation in vivo therapy platforms.
Seminars
Wednesday 16th September 2026
Panel Discussion: Aligning Preclinical Model Selection with Regulatory Expectations to Improve Translation & Approval Confidence
2:30 pm
- Evaluating mouse and non-human primate model translatability to improve clinical predictability
- Comparing model suitability across therapy types to highlight strategic differences that reduce regulatory risk
- Discussing gaps between required regulatory model data and biopharma efficacy needs to align development strategies with translational approval
Tuesday 15th September 2026
Non-Viral ssDNA Vector Delivery Strategies to Optimize Persistence & Patient Safety
1:30 pm
- In vivo immune cell engineering with ssDNA
- Developing strategies to allow long term persistence and gene expression
- Preclinical evidence and scale up
